Around the Web — 12.09.22
FDA yesterday amended the emergency use authorizations of the updated (bivalent) Moderna and Pfizer-BioNTech COVID-19 vaccines to include use in children as young as 6
Michael Posey
December 9, 2022
FDA yesterday amended the emergency use authorizations of the updated (bivalent) Moderna and Pfizer-BioNTech COVID-19 vaccines to include use in children as young as 6
Homeopathic products intended for use by those with weakened immune systems, infants and children, older adults, and pregnant women, as well as ophthalmic and injectable
Remote filling of prescriptions by CVS Health is examined in a Wall Street Journal report. The company touts the practice as a way of addressing
The emergency use authorization (EUA) for bebtelovimab, the only COVID-19 antibody treatment remaining on the U.S. market, was withdrawn yesterday because of lack of efficacy
The FDA and the National Institute of Standards and Technology are collaborating on a project to develop and harmonize methods to standardize the description of the temperature
FDA yesterday released a finalized guidance on “Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile
FDA yesterday approved etranacogene dezaparvovec (Hemgenix, CSL Behring), an adeno-associated virus vector-based gene therapy for the treatment of adults with hemophilia B (congenital factor IX
Pharmacy benefits managers could find themselves in the crosshairs of Congress in coming months, the Wall Street Journal reports: “Targeting PBMs has increasingly become a
The first agent indicated for the delay of the onset of stage 3 type 1 diabetes, teplizumab-mzwv (Tzield, Provention Bio) injection, was approved yesterday by
FDA issued warning letters to 5 firms for the unauthorized marketing of 15 different e-cigarette products that are packaged to look like toys, food, or